Concepedia

Jinghan Li

JL

Statistics

Publications

12

Citations

404

H-Index

11

Active since

2019

Affiliations

Hebei University of Chinese Medicine(Current)

Fourth Hospital of Hebei Medical University

Hebei Medical University

Jinghan Li is an author at Hebei University of Chinese Medicine specializing in cardioprotective therapy, pharmacology, and nrf2 pathway activation.

ORCID

Publications per year

2019–2024

12

Publications

12

Hesperetin modulates the Sirt1/Nrf2 signaling pathway in counteracting myocardial ischemia through suppression of oxidative stress, inflammation, and apoptosis

Panpan Liu, Jinghan Li, Miaomiao Liu et al. · Biomedicine & Pharmacotherapy · 2021 · 102 citations · Full text

, , +15

Crocin ameliorates arsenic trioxide‑induced cardiotoxicity via Keap1-Nrf2/HO-1 pathway: Reducing oxidative stress, inflammation, and apoptosis

Yingran Liang, Bin Zheng, Jinghan Li et al. · Biomedicine & Pharmacotherapy · 2020 · 72 citations · Full text

, , +17

Influence of artificial intelligence (AI) perception on career resilience and informal learning

Haiyan Kong, Xinyu Jiang, Xiaoge Zhou et al. · Tourism Review · 2023 · 60 citations

, , +10

Ameliorative effects and mechanism of crocetin in arsenic trioxide‑induced cardiotoxicity in rats

Zhifeng Zhao, Jinghan Li, Bin Zheng et al. · Molecular Medicine Reports · 2020 · 36 citations · Full text

, , +12

The protective mechanism of resveratrol against hepatic injury induced by iron overload in mice

Jinghan Li, Simeng Wang, Jiaqi Duan et al. · Toxicology and Applied Pharmacology · 2021 · 30 citations

, , +16

1–5 of 12